Skip to main content
Clinical Trials/IRCT20230902059325N1
IRCT20230902059325N1
Recruiting
Phase 3

Comparison of the efficacy and side effects of Desmopressin melting tablets and nasal spray in the treatment of primary enuresis in children aged 6 to 12 years

Mashhad University of Medical Sciences0 sites220 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Mashhad University of Medical Sciences
Enrollment
220
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 6 to 12 years old
  • Single\-symptom nocturnal enuresis
  • Able to use nasal spray or sublingual tablets
  • Completion of the informed consent form by the guardian or legal guardian
  • At least two weeks before the start of the study, he did not receive any medicine

Exclusion Criteria

  • Having a history of organic urological disease, daily urinary incontinence, diabetes insipidus, or persistent urinary tract infection
  • Having clinically significant renal, hepatic, gastrointestinal, pulmonary, cardiovascular, endocrine, or neurological disease that interferes with evaluation
  • Using antibiotics, diuretics or any medicine that affects the concentration of urine
  • Failure to complete the informed consent form

Outcomes

Primary Outcomes

Not specified

Similar Trials